Summary:
In this podcast, from the 2024 Immuno-Oncology 360º Summit, Dr Ira Mellman, Genentech's VP of Cancer Immunology, discusses the powerful combination of AI and empirical science, particularly:
- The "lab in a loop" concepts with examples, limitations and potential
- The impact for personalized mRNA/DNA vaccines, cell therapies, TIGIT and more
- What this means for the future of clinical discovery in cancer immunotherapy
For more information, visit immuno-oncology360.org
Speakers
Ira Mellman, PhD
President of Research
Parker Institute for Cancer Immunotherapy (PICI)
This content was created by The Conference Forum staff. The Fierce editorial team did not contribute to this work.